South America Calciphylaxis Market
South America Calciphylaxis Market Research Report: By Diagnosis (Deep Skin Biopsies, Blood Tests, Imaging), By Treatment (Intensive Wound Care, Medication, Therapy, Clot-Dissolving), By End User (Hospitals, Clinics, Medical Research Centers) andBy Regional (Brazil, Mexico, Argentina, Rest of South America)- Forecast to 2035
Industry Developments
Recent developments in the South America Calciphylaxis Market include an increased focus on targeted therapies and innovative treatment options due to the rising incidence of chronic kidney disease in the region. Companies like Novartis AG and AbbVie Inc. are actively pursuing Research and Development initiatives aimed at better management of calciphylaxis. Additionally, the market valuation for companies such as Merck and Company and Amgen Inc. has seen growth, driven by advancements in treatment modalities and increased healthcare expenditure in South America. A notable event was the acquisition of a biotechnology firm by Fresenius Medical Care in July 2022, aimed at enhancing their product offerings for renal patients. Furthermore, in March 2023, Eli Lilly and Company announced a collaboration with local health organizations in Brazil to develop educational programs for healthcare professionals dealing with calciphylaxis cases. The South American healthcare landscape is evolving, with governments investing in public health infrastructure, bolstering the market for calciphylaxis treatments and thus encouraging partnerships among major pharmaceutical players such as Johnson and Johnson and Roche Holding AG for regional expansion initiatives.
Report Scope
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 132.01(USD Million) |
| MARKET SIZE 2024 | 146.93(USD Million) |
| MARKET SIZE 2035 | 1116.79(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 20.248% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Novartis AG, Thermo Fisher Scientific, AbbVie Inc., GlaxoSmithKline, Celgene Corporation, Fresenius Medical Care, Baxter International, Merck & Co., Eli Lilly and Company, Amgen Inc., DaVita Inc., BristolMyers Squibb, Sanofi, Johnson & Johnson, Roche Holding AG |
| SEGMENTS COVERED | Diagnosis, Treatment, End User, Regional |
| KEY MARKET OPPORTUNITIES | Rising incidences of chronic kidney disease, Increased awareness among healthcare professionals, Development of targeted therapies, Growing number of research initiatives, Enhanced patient support programs |
| KEY MARKET DYNAMICS | increasing prevalence of kidney disease, limited treatment options available, rising awareness and diagnosis, healthcare infrastructure challenges, growing investment in research |
| COUNTRIES COVERED | Brazil, Mexico, Argentina, Rest of South America |
FAQs
What is the projected market size of the South America Calciphylaxis Market in 2024?
The South America Calciphylaxis Market is projected to be valued at 146.93 million USD in 2024.
What is the expected market size of the South America Calciphylaxis Market by 2035?
By 2035, the South America Calciphylaxis Market is expected to reach 1116.79 million USD.
What is the projected CAGR for the South America Calciphylaxis Market between 2025 and 2035?
The expected CAGR for the South America Calciphylaxis Market is 20.248% from 2025 to 2035.
Which country holds the largest market share in the South America Calciphylaxis Market in 2024?
In 2024, Brazil is projected to hold the largest market share at 40.0 million USD.
What is the market size for Blood Tests in the South America Calciphylaxis Market in 2024?
The market size for Blood Tests in 2024 is valued at 62.93 million USD.
How much is the market for Deep Skin Biopsies expected to be worth in 2035?
The market for Deep Skin Biopsies is expected to reach 368.0 million USD by 2035.
Who are the key players in the South America Calciphylaxis Market?
Key players in the South America Calciphylaxis Market include Novartis AG, AbbVie Inc., and Merck & Co.
What is the projected market size for Argentina in the South America Calciphylaxis Market in 2035?
Argentina's market size is projected to reach 200.0 million USD by 2035.
What is the forecasted growth for the Rest of South America segment by 2035?
The Rest of South America segment is expected to grow to 366.79 million USD by 2035.
What are the expected market conditions for Imaging diagnostics within the South America Calciphylaxis Market in 2024?
The Imaging diagnostics market is projected to be valued at 36.0 million USD in 2024.
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
“Thank you, this will be very helpful for OQS.”
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Leave a Comment